|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 600 articles |
 Page 1 of 8 
|
Summit begins SMT D002 trial.
October 29, 2007
HPV test 40% more accurate than Pap smear.
October 29, 2007
York establishes dosage of Sabarep for Ph IIb trial.
October 29, 2007
EUSA's Rapydan completes European MRP.
October 29, 2007
Pediatric drugs: lack of incentives for research in off-patent product...
October 29, 2007
EFPIA response to the European Commission on the future of pharmaceuti...
October 29, 2007
UPDATE: 2007 NASSO conference hears encouraging data on GSK's alli, Or...
October 29, 2007
Stock Commentary - Europe - week to October 22, 2007.
October 29, 2007
Stock Commentary - New York week to October 22, 2007.
October 29, 2007
Noven gets FDA "approvable letter" for Stavzor.
October 29, 2007
Bangladesh's Beximco now exporting to Fiji.
October 29, 2007
Targacept to advance drug into clinicals.
October 29, 2007
Merck & Co discontinues HIV vacc trial.
October 29, 2007
Strong PAH data for Tracleer plus sildenafil.
October 29, 2007
FDA accepts ANDA for Par's generic Focalin.
October 29, 2007
FDA OKs bioMerieux' ICT sepsis assay.
October 29, 2007
Ardea's MEK inhibitor delays tumor growth in animal models.
October 29, 2007
Vanda hires Al Gianchetti as senior VP and CCO.
October 29, 2007
Stephen Ferrone joins Immunosyn as CEO, president and board member.
October 29, 2007
Three new senior appointments at Aesica.
October 29, 2007
BR Pharma appoints Rosemary Bensley managing director.
October 29, 2007
Celldex and Avant sign definitive all-stock merger agreement.
October 29, 2007
Bioenvision stockholders approve aquisition by Genzyme.
October 29, 2007
AmVac AG names Michel Klein head of vaccine R&D.
October 29, 2007
PPD opens four new offices.
October 29, 2007
FDA c'ttee recommends expanded indication for FluMist.
October 29, 2007
Two prasugrel trials suspended on dosage issues.
October 29, 2007
Solvay to co-promote Abbott's Simcor in USA.
October 29, 2007
FDA approves Genzyme's Renvela.
October 29, 2007
Amgen files romiplostim NDA with US FDA.
October 29, 2007
Wyeth submits Tygacil sNDA for CAP.
October 29, 2007
US government "wasting $100M" on anthrax drugs.
October 29, 2007
Pfizer closes R&D facility threatened by California fires.
October 29, 2007
Strong Ph IIb data on Orexigen's Contrave.
October 29, 2007
US medical students urge schools to stop pharma marketing influence.
October 29, 2007
Headlines 25 years ago this week....
October 29, 2007
New head of Wyeth France to manage future growth.
October 29, 2007
GSK's malaria vacc achieves proof-of-concept in Ph I/II trial.
October 29, 2007
Strong safety data for Cytori's Celution System.
October 29, 2007
Positive Ph II safety data on S-P's TRA.(Clinical report)
October 29, 2007
EC reinstates Roche's Viracept.
October 29, 2007
Stada's Silapo gets CHMP thumbs up.
October 29, 2007
CHMP recommends approval of Atripla for HIV-1.
October 29, 2007
CHMP advocates MabCampath approval.
October 29, 2007
Abraxane gets CHMP nod for breast cancer.
October 29, 2007
CHMP recommends Taxotere SCCHN approval expansion.
October 29, 2007
Japan stock market week to Oct 22, 2007.
October 29, 2007
Lower Avandia Rxing and generics take a toll on GlaxoSmithKline's thir...
October 29, 2007
Merck KGaA's net falls but beats forecasts.(Financial report)
October 29, 2007
GSK and Mylan settle Paxil IP dispute.
October 29, 2007
Amgen wins in Roche Mircera patent suit.
October 29, 2007
Spanish court upholds Pfizer's Lipitor patent.
October 29, 2007
Novartis' Exelon patch launched in the UK.
October 29, 2007
GSK enters global TRX4 alliance with Tolerx.
October 29, 2007
US FDA "approvable letter" for telavancin.
October 29, 2007
UPDATE: Thailand negotiations on drug prices continue.
October 29, 2007
31M Indonesian children get measles vaccine.
October 29, 2007
XDR-TB "created by 2001 WHO campaign".
October 29, 2007
Actelion's 9-month net profit declines to $30.6M.(Financial report)
October 29, 2007
Merck & Co's 3rd-qtr 2007 sales jump 12%.(Financial report)
October 29, 2007
EMEA: Avandia/Actos benefits outweigh risks.
October 29, 2007
CHMP advises withdrawal of clobutinol-based cough drugs.
October 29, 2007
GSK's allergy drug gets positive CHMP opinion.
October 29, 2007
Alcon's Nevanac impresses CHMP.
October 29, 2007
Stem Cell Sci to develop novel agents for drug discovery.
October 29, 2007
Gilead announces $3 billion share buyback.
October 29, 2007
Positive preclinical results for Can-Fite's CF102.
October 29, 2007
Amylin's 3rd-qtr net loss narrows to $39.8M.(Financial report)
October 29, 2007
Galderma symposium provides useful expert forum.
October 29, 2007
Hospira's Retacrit gets CHMP thumbs up.
October 29, 2007
Rx Project report shows industry spends $50M on marketing cold product...
October 29, 2007
Ablynx launches European IPO.
October 29, 2007
Advaxis in deal with Cobra for Lovaxin.
October 29, 2007
Omiganan achieves dose-dependant response in rosacea.
October 29, 2007
NicOx opens US base in New Jersey.
October 29, 2007
|
1